WHO ICTRP trial
Comparison of the effect of adding Neostigmine to Ropivacaine and sufentanilto…
IRCT20141209020258N107 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20141209020258N107 |
|---|---|
| Public title | Comparison of the effect of adding Neostigmine to Ropivacaine and sufentanilto Ropivacaine in spinal anesthesia for herniorrhaphy surgery |
| Scientific title | Comparison of the effect of adding Neostigmine to Ropivacaine and sufentanilto Ropivacaine in spinal anesthesia for herniorrhaphy surgery |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Spinal anesthesia. Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances |
| Interventions | Intervention 1: Intervention group: We inject 3 milliliter of Ropivacaine(15 milligram) plus 50 micro gram Neostigmine (Caspian.Co.Rasht)(1 milliliter) in form of intrathecal. Intervention 2: Intervention group: We inject 3 milliliter of… |
| Registration date | Apr 23, 2019 |
| Target size | 105 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: